Mr.John Gillen

European Pioneer of Nad+




For over a decade he has travelled the world to obtain answers. This led to the realisation that the co-enzyme NAD+ Nicotinamide adenine dinucleotide, was the central metabolite required for cell function. John explains it quite simply as being the "miracle molecule", finding scientific evidence for this cellular fuel, realising the potential for numerous conditions with NAD+ as the vital component for regenerative medicine." And as a Anti Ageing Therapy NADCELL now offers NAD+ Intravenous therapy John was the first pioneer to bring Nad+ treatment to Europe in 2013 Johns' passion extends to other metabolic disturbances and neurodegenerative diseases.